Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration
Abstract CRISPR-Cas13 systems have therapeutic promise for the precise correction of point mutations in RNA. Using adenosine deaminase acting on RNA (ADAR) effectors, A-I base conversions can be targeted using guide RNAs (gRNAs). We compare the Cas13 effectors PspCas13b and Cas13bt3 for the repair o...
Saved in:
Main Authors: | Lewis E. Fry, Lauren Major, Ahmed Salman, Lucy A. McDermott, Jun Yang, Andrew J. King, Michelle E. McClements, Robert E. MacLaren |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-025-07557-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Rise of CRISPR/Cas for Genome Editing in Stem Cells
by: Bing Shui, et al.
Published: (2016-01-01) -
Principles and medical applications of gene editing by CRISPR / Cas
by: Rolando Sánchez Artigas, et al.
Published: (2021-12-01) -
CRISPR/Cas9-editing of PRNP in Alpine goats
by: Aurélie Allais-Bonnet, et al.
Published: (2025-01-01) -
Crop genes modified using CRISPR/Cas system
by: A. M. Korotkova, et al.
Published: (2017-04-01) -
CRISPR/Cas genome editing for cotton precision breeding: mechanisms, advances, and prospects
by: Vijay Sheri, et al.
Published: (2025-02-01)